Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
about
Comparative analysis of the EGFR, HER2, c-MYC, and MET variations in colorectal cancer determined by three different measures: gene copy number gain, amplification status and the 2013 ASCO/CAP guideline criterion for HER2 testing of breast cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Comparative analysis of the EG ...... HER2 testing of breast cancer.
@en
type
label
Comparative analysis of the EG ...... HER2 testing of breast cancer.
@en
prefLabel
Comparative analysis of the EG ...... HER2 testing of breast cancer.
@en
P2093
P2860
P1476
Comparative analysis of the EG ...... HER2 testing of breast cancer.
@en
P2093
Duck Woo Kim
Heung-Kwon Oh
Hye Seung Lee
Kyu Sang Lee
Soo Kyung Nam
Sung Bum Kang
Woo Ho Kim
P2860
P2888
P356
10.1186/S12967-017-1265-X
P577
2017-08-01T00:00:00Z
P6179
1090948454